Noxopharm Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 19 shareholders own 34.81% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.7%	Graham Kelly	34,249,106	AU$4.6m	0%	no data
3.75%	Eleanore Goodridge	10,959,511	AU$1.5m	10%	no data
3.62%	Laurence Freedman	10,586,522	AU$1.4m	0%	no data
2.57%	Frederick Bart	7,507,813	AU$1.0m	0%	no data
2.22%	Rgt Capital Fund No 5 (Noxo) Pty Ltd	6,500,333	AU$877.5k	0%	no data
1.71%	Kale Capital Corporation Limited	4,997,437	AU$674.7k	0%	no data
1.39%	James Schwarz	4,066,400	AU$549.0k	-4.38%	no data
1.06%	Nora Goodridge Investments Pty Ltd	3,090,489	AU$417.2k	0%	no data
1.03%	Rhlc Pty Ltd	3,000,000	AU$405.0k	-6.25%	no data
1%	Lizhong Yu	2,918,000	AU$393.9k	0%	no data
0.92%	Richard Gelski	2,686,376	AU$362.7k	0%	no data
0.86%	Robert Lin	2,500,000	AU$337.5k	0%	no data
0.66%	Sophie Gelski	1,942,424	AU$262.2k	0%	no data
0.6%	Ian Dixon	1,751,246	AU$236.4k	0%	no data
0.55%	Jin Qin Wang	1,600,000	AU$216.0k	0%	no data
0.32%	Michael Shabat	921,500	AU$124.4k	8.23%	no data
0.32%	Meital Shabat	921,500	AU$124.4k	8.23%	no data
0.31%	Peter Marks	900,000	AU$121.5k	0%	no data
0.22%	Boris Patkin	630,000	AU$85.1k	0%	no data